CP8 – ProWide

Patient Reported Outcomes used for Weekly Internet-based Decetion of progressive disease in lung cancer; a randomized controlled trial: ProWide

Rasmus Blechingberg Friis, læge, ph.d studerende, onkologisk afdeling, Hospitalsenhed Vest, Herning

Status oktober 2023
The ProWide study evaluates the effect of remote electronic symptom monitoring in patients with lung cancer. The project is a national randomized controlled study, in which eight of ten. Danish Cancer Departments participate.

The status of the ProWide study is that the trial has ended. The results were presented at an oral presentation at ASCO 2023. The study is expected to be submitted within a few months.

The register based substudy, has been initiated and will compare socioeconomic differences between participants in the study population with a comparable population of patients with lung cancer.

Two qualitative sub-studies have been conducted. One is in review, the next is in preparation process. The last has been delayed because the person responsible has changed job.

According to the original plan, the study would have reached full follow-up and had been published at the end of 2022. Due to delayed inclusion and several closures of enrolment, caused by the Covid-19 pandemic, the study has not been mature for publication until now.

Electronic symptom monitoring in patients with metastatic lung cancer: a feasibility study, 2020 Jun 17;10(6):e035673. doi: 10.1136/bmjopen-2019-035673.

Exploring the Nurses’ Perspective on Using Remote Electronic Symptom Monitoring in Clinical Decision-Making Among Patients With Metastatic Lung Cancer In press https://doi.org/10.1016/j.soncn.2023.151517